CATO SMS Trademark

Trademark Overview


On Wednesday, January 22, 2020, a trademark application was filed for CATO SMS with the United States Patent and Trademark Office. The USPTO has given the CATO SMS trademark a serial number of 88981012. The federal status of this trademark filing is REGISTERED as of Tuesday, June 15, 2021. This trademark is owned by Clinical Services Corporate Operations,Inc.. The CATO SMS trademark is filed in the Advertising, Business and Retail Services, Education & Entertainment Services, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:

providing statistical information and analysis, data processing, project planning and cost management services for preclinical and clinical trials in the fields of pharmaceuticals, biotechnology, medical devices and diagnostics; designing laboratory research, namely, managing and monitoring preclinical and clinical trials; data management, namely, abstraction and collection of medical data from clinical tests for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries

training and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support

data management, namely, collection of patient-generated health data for scientific research purposes; Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to t...

development of regulatory compliance strategies in the field of medical research, namely, regulatory compliance in drug, biologic, cosmetic and medical device development
cato sms

General Information


Serial Number88981012
Word MarkCATO SMS
Filing DateWednesday, January 22, 2020
Status700 - REGISTERED
Status DateTuesday, June 15, 2021
Registration Number6391003
Registration DateTuesday, June 15, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2020

Trademark Statements


Disclaimer with Predetermined Text"SMS" IN INTERNATIONAL CLASS 42
Goods and Servicesproviding statistical information and analysis, data processing, project planning and cost management services for preclinical and clinical trials in the fields of pharmaceuticals, biotechnology, medical devices and diagnostics; designing laboratory research, namely, managing and monitoring preclinical and clinical trials; data management, namely, abstraction and collection of medical data from clinical tests for business purposes; Market research and business marketing consulting services in the pharmaceutical, biotechnology, medical device, and diagnostics industries
Goods and Servicestraining and development in the field of conducting clinical trials, namely, conducting tutorials, seminars and workshops in the field of clinical trials; training in the field of computer software support, namely, conducting tutorials, seminars and workshops in the field of software support
Goods and Servicesdata management, namely, collection of patient-generated health data for scientific research purposes; Cloud computing featuring software that allows users to collect, review, analyze and report on clinical research; technical support services, namely, installation and remote administration of software, and troubleshooting of software problems and hosted software applications, all for use in connection with medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; cloud computing featuring software for providing telehealth, telemedicine, remote care and virtual health care services to patients; cloud computing featuring software that allows users to collect, track, retrieve, validate, summarize, statistically analyze and present data used in the areas of medical research and product regulatory approval, environmental health, health care, and in relation to the design, research, development, and testing of new medical products and devices; Cloud computing featuring software to aggregate, integrate, transfer and manage data generated from home health and remote monitoring devices and applications and health-related smart-phone applications; Cloud computing featuring software that provides integrated workflows, analytics, visualizations, and reporting features to deliver, process, analyze, elevate, and display patient-generated health data; Cloud computing featuring software that integrates remotely collected health data into databases, systems, platforms, applications, and software that inform clinical research, remote monitoring, and care management; providing a web-based portal for study sponsors and contract research organizations (CROs) to build programs, enroll members, automate actions, and visualize/analyze data in connection with clinical studies; technical consulting services, namely, evaluating the safety of pharmaceutical, medical, cosmetic and consumer devices and products in clinical development or in commercial production
Goods and Servicesdevelopment of regulatory compliance strategies in the field of medical research, namely, regulatory compliance in drug, biologic, cosmetic and medical device development

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, January 27, 2020
Primary Code035
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateMonday, January 27, 2020
Primary Code041
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 27, 2020
Primary Code042
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 27, 2020
Primary Code045
First Use Anywhere DateTuesday, September 1, 2020
First Use In Commerce DateTuesday, September 1, 2020

Trademark Owner History


Party NameClinical Services Corporate Operations,Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02452

Party NameClinical Services Corporate Operations,Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02452

Party NameClinical Services Corporate Operations,Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02452

Trademark Events


Event DateEvent Description
Tuesday, June 15, 2021REGISTERED-PRINCIPAL REGISTER
Wednesday, May 12, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 11, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, April 12, 2021EXAMINER'S AMENDMENT ENTERED
Monday, April 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 12, 2021EXAMINERS AMENDMENT E-MAILED
Monday, April 12, 2021SU-EXAMINER'S AMENDMENT WRITTEN
Wednesday, March 17, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, February 24, 2021USE AMENDMENT FILED
Wednesday, March 17, 2021DIVISIONAL PROCESSING COMPLETE
Wednesday, February 24, 2021DIVISIONAL REQUEST RECEIVED
Monday, March 15, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 24, 2021TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 24, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, August 25, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 26, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 26, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 21, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, May 21, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 21, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, May 21, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION WRITTEN
Saturday, April 25, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 11, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 11, 2020NON-FINAL ACTION E-MAILED
Saturday, April 11, 2020NON-FINAL ACTION WRITTEN
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Monday, January 27, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 25, 2020NEW APPLICATION ENTERED IN TRAM